📅 Upcoming Events
📅 23–26 February 2026
📍 Eilat, Israel
Vidac Pharma will attend the 11th ILANIT / FISEB Conference, a leading international forum at the interface of life sciences, medicine, and biotechnology.
The company will be represented by:
- Prof. Max Herzberg (Chief Executive Officer)
- Dr. Eyal Breitbart (Chief Technology Officer)
For more information, please visit: https://conf.fiseb.org/
Past Events
2025
📅 3 December 2025
Vidac Pharma invited to present at the 17th International Investment Forum.
📅 23 October 2025
Vidac Pharma to present possible cooperation with Johnson and Johnson specialists.
📅 4 March 2025
Vidac Pharma Holding PLC announces participation in the first pediatric brain tumor research meeting.
📅 24–25 February 2025
📍 Frankfurt and Munich, Germany
Vidac Pharma Holding Plc Investor Roadshow.
📅 26–27 February 2025
📍 Zürich, Switzerland
Vidac Pharma invited to Sachs Annual European Life Sciences CEO Forum.
📅 23 January 2025
📍 Google Campus, Tel Aviv
Dr. Max Herzberg participates in innovative brain cancer meeting.
2024
📅 28–29 February 2024
📍 Zurich, Switzerland
Vidac Pharma CEO Prof. Max Herzberg presented results related to the VDA-1275 program, including synergistic effects observed in organoid models of solid tumors.
2023
📅 24–25 October 2023
📍 Paris, France
Vidac Pharma participated in HTID 5, where CEO Prof. Max Herzberg chaired an expert panel on non-violent cancer therapies.
2022
📅 13–14 October 2022
📍 Paris, France
Vidac Pharma was selected among innovative companies to pitch during HTID 4 and was awarded an innovation prize.
2019 and Earlier
📅 6–8 January 2019 | 📍 San Francisco, CA, USA
📅 7–11 November 2018 | 📍 Washington, D.C., USA
📅 18–21 October 2018 | 📍 Las Vegas, NV, USA
📅 30 June – 3 July 2018 | 📍 Amsterdam, Netherlands
📅 19 June 2018 | 📍 New York, NY, USA
📅 14–18 April 2018 | 📍 Chicago, IL, USA